Characterizing experiences of non-medical switching to trastuzumab biosimilars using data from internet-based surveys with US-based oncologists and breast cancer patients

PURPOSE: To characterize current experiences with communication and decision-making practices when non-medical switching to a biosimilar trastuzumab is proposed or required by cancer center or insurer. METHODS: We developed and launched 60- and 51-item internet surveys to elicit US breast cancer pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Papautsky, Elizabeth Lerner, Carlson, Martha, Johnson, Sheila M., Montague, Hannah, Attai, Deanna J., Lustberg, Maryam B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Preclinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9107314/
https://www.ncbi.nlm.nih.gov/pubmed/35568748
http://dx.doi.org/10.1007/s10549-022-06615-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9107314/
https://www.ncbi.nlm.nih.gov/pubmed/35568748
http://dx.doi.org/10.1007/s10549-022-06615-2

Ejemplares similares